Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. more
Time Frame | ABT | Sector | S&P500 |
---|---|---|---|
1-Week Return | 1.4% | -0.33% | -1.49% |
1-Month Return | -2.75% | -4.57% | -0.37% |
3-Month Return | 1.36% | -9.96% | 3.89% |
6-Month Return | 9.1% | -5.67% | 9.34% |
1-Year Return | 5.17% | 2.53% | 25.19% |
3-Year Return | -18.79% | -1.43% | 24.7% |
5-Year Return | 31.62% | 34.73% | 85.39% |
10-Year Return | 151.38% | 102.14% | 187.19% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 31.90B | 34.61B | 43.08B | 43.65B | 40.11B | [{"date":"2019-12-31","value":73.09,"profit":true},{"date":"2020-12-31","value":79.28,"profit":true},{"date":"2021-12-31","value":98.68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.88,"profit":true}] |
Cost of Revenue | 13.23B | 15.00B | 18.54B | 19.14B | 17.98B | [{"date":"2019-12-31","value":69.12,"profit":true},{"date":"2020-12-31","value":78.38,"profit":true},{"date":"2021-12-31","value":96.84,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.9,"profit":true}] |
Gross Profit | 18.67B | 19.61B | 24.54B | 24.51B | 22.13B | [{"date":"2019-12-31","value":76.1,"profit":true},{"date":"2020-12-31","value":79.9,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.89,"profit":true},{"date":"2023-12-31","value":90.2,"profit":true}] |
Gross Margin | 58.53% | 56.65% | 56.97% | 56.15% | 55.18% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":96.79,"profit":true},{"date":"2021-12-31","value":97.33,"profit":true},{"date":"2022-12-31","value":95.94,"profit":true},{"date":"2023-12-31","value":94.29,"profit":true}] |
Operating Expenses | 14.14B | 14.25B | 16.11B | 16.15B | 15.66B | [{"date":"2019-12-31","value":87.57,"profit":true},{"date":"2020-12-31","value":88.23,"profit":true},{"date":"2021-12-31","value":99.78,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.95,"profit":true}] |
Operating Income | 4.53B | 5.36B | 8.43B | 8.36B | 6.48B | [{"date":"2019-12-31","value":53.79,"profit":true},{"date":"2020-12-31","value":63.58,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.25,"profit":true},{"date":"2023-12-31","value":76.89,"profit":true}] |
Total Non-Operating Income/Expense | (1.03B) | (889.00M) | (704.00M) | (431.00M) | (62.00M) | [{"date":"2019-12-31","value":-103100000000,"profit":false},{"date":"2020-12-31","value":-88900000000,"profit":false},{"date":"2021-12-31","value":-70400000000,"profit":false},{"date":"2022-12-31","value":-43100000000,"profit":false},{"date":"2023-12-31","value":-6200000000,"profit":false}] |
Pre-Tax Income | 4.08B | 4.97B | 8.21B | 8.31B | 6.66B | [{"date":"2019-12-31","value":49.08,"profit":true},{"date":"2020-12-31","value":59.81,"profit":true},{"date":"2021-12-31","value":98.86,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":80.23,"profit":true}] |
Income Taxes | 390.00M | 497.00M | 1.14B | 1.37B | 941.00M | [{"date":"2019-12-31","value":28.4,"profit":true},{"date":"2020-12-31","value":36.2,"profit":true},{"date":"2021-12-31","value":83.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":68.54,"profit":true}] |
Income After Taxes | 3.69B | 4.47B | 7.07B | 6.93B | 5.72B | [{"date":"2019-12-31","value":52.14,"profit":true},{"date":"2020-12-31","value":63.23,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.05,"profit":true},{"date":"2023-12-31","value":80.94,"profit":true}] |
Income From Continuous Operations | 3.69B | 4.47B | 7.07B | 6.93B | 5.16B | [{"date":"2019-12-31","value":52.14,"profit":true},{"date":"2020-12-31","value":63.23,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.05,"profit":true},{"date":"2023-12-31","value":73,"profit":true}] |
Income From Discontinued Operations | 24.00M | 24.00M | - | - | - | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 3.69B | 4.50B | 7.07B | 6.93B | 5.72B | [{"date":"2019-12-31","value":52.14,"profit":true},{"date":"2020-12-31","value":63.57,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.05,"profit":true},{"date":"2023-12-31","value":80.94,"profit":true}] |
EPS (Diluted) | 3.24 | 3.65 | 5.21 | 5.34 | 4.44 | [{"date":"2019-12-31","value":60.67,"profit":true},{"date":"2020-12-31","value":68.35,"profit":true},{"date":"2021-12-31","value":97.57,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":83.15,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
ABT | |
---|---|
Cash Ratio | 0.52 |
Current Ratio | 1.60 |
Quick Ratio | 1.14 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
ABT | |
---|---|
ROA (LTM) | 6.49% |
ROE (LTM) | 14.84% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
ABT | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.46 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.54 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
ABT | |
---|---|
Trailing PE | 34.88 |
Forward PE | 22.17 |
P/S (TTM) | 4.83 |
P/B | 4.98 |
Price/FCF | 93 |
EV/R | 4.98 |
EV/Ebitda | 19.41 |
PEG | 2.21 |
Abbott Laboratories (ABT) share price today is $114.76
Yes, Indians can buy shares of Abbott Laboratories (ABT) on Vested. To buy Abbott Laboratories from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ABT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Abbott Laboratories (ABT) via the Vested app. You can start investing in Abbott Laboratories (ABT) with a minimum investment of $1.
You can invest in shares of Abbott Laboratories (ABT) via Vested in three simple steps:
The 52-week high price of Abbott Laboratories (ABT) is $121. The 52-week low price of Abbott Laboratories (ABT) is $99.24.
The price-to-earnings (P/E) ratio of Abbott Laboratories (ABT) is 34.8815
The price-to-book (P/B) ratio of Abbott Laboratories (ABT) is 4.98
The dividend yield of Abbott Laboratories (ABT) is 2.07%
The market capitalization of Abbott Laboratories (ABT) is $199.05B
The stock symbol (or ticker) of Abbott Laboratories is ABT